Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NATCO Pharma Limited ( (IN:NATCOPHARM) ) has shared an update.
Natco Pharma Limited has announced the publication of its 42nd Annual General Meeting details in prominent newspapers, Financial Express and Nava Telangana, as part of regulatory compliance. This announcement underscores the company’s commitment to transparency and adherence to regulatory requirements, which may enhance its reputation among stakeholders and investors.
More about NATCO Pharma Limited
Natco Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of generic medicines. The company is known for its expertise in oncology and specialty pharmaceuticals, serving markets across the globe.
Average Trading Volume: 74,333
Technical Sentiment Signal: Sell
Current Market Cap: 154.3B INR
Find detailed analytics on NATCOPHARM stock on TipRanks’ Stock Analysis page.